What is TransMedics Group, Inc.'s convertible debentures?

TransMedics Group, Inc. (TMDX) reported convertible debentures of $453.53M in Q1 2026.

How has TransMedics Group, Inc.'s convertible debentures changed year-over-year?

TransMedics Group, Inc.'s convertible debentures increased by 0.6% year-over-year, from $450.65M to $453.53M.

What is the long-term trend for TransMedics Group, Inc.'s convertible debentures?

Over 2 years (2023 to 2025), TransMedics Group, Inc.'s convertible debentures has grown at a 0.6% compound annual growth rate (CAGR), from $447.14M to $452.8M.

TransMedics Group, Inc. TMDX Convertible debentures

Convertible debentures at other companies

DexComDXCM

$0—

DropboxDBX

$690.3M+0.2%

Mirum Pharmaceuticals, Inc.MIRM

$310.25M+0.6%

NTS

Netskope, Inc. Class A Common StockNTSK

$713.32M—

Nutanix, Inc.NTNX

$1.35B+0.4%

Applied OptoelectronicsAAOI

$129.52M-3.5%

Other financials

Income statement

See full

Revenue$173.9M+21.2%

Gross profit$101.2M+14.7%

Operating income$13.3M-51.5%

Net income$7.3M-71.5%

EPS (diluted)$0.20-71.4%

Balance sheet

See full

Cash & equivalents$461.7M+48.9%

Total debt$409.9M+505%

Total equity$494.0M+85.5%

Total assets$1.4B+71.3%

Cash flow

See full

Operating cash flow$24.5M+959%

CapEx$36.7M+35.6%

Free cash flow-$12.1M+59.4%

Valuation

See full

Market cap$2.55B+50.6%

Enterprise value$2.5B+66.0%

P/E14.8×-19.8×

P/S4×+0.5×

Profitability

See full

Gross margin59.1%-0.4pp

Operating margin14.9%+4.1pp

Net margin27%+17.0pp

FCF margin23.8%—

Returns & leverage

See full

Return on equity45.2%+22.2pp

Debt / equity0.8×+0.6×

Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s convertible debentures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransMedics Group, Inc.'s convertible debentures?: TransMedics Group, Inc. (TMDX) reported convertible debentures of $453.53M in Q1 2026.
How has TransMedics Group, Inc.'s convertible debentures changed year-over-year?: TransMedics Group, Inc.'s convertible debentures increased by 0.6% year-over-year, from $450.65M to $453.53M.
What is the long-term trend for TransMedics Group, Inc.'s convertible debentures?: Over 2 years (2023 to 2025), TransMedics Group, Inc.'s convertible debentures has grown at a 0.6% compound annual growth rate (CAGR), from $447.14M to $452.8M.